Prostaglandin Receptors in Primate Ovulatory Follicles
灵长类动物排卵卵泡中的前列腺素受体
基本信息
- 批准号:7481086
- 负责人:
- 金额:$ 34.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-09 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAgonistAndro-DianeAntralAttentionBasement membraneCell physiologyCellsContraceptive AgentsDataDetectionDevelopmentDinoprostoneDoseEndopeptidasesEventFailureFertilizationG-Protein-Coupled ReceptorsGasesGenerationsGonadotropinsHumanIn VitroInfertilityInjection of therapeutic agentInvestigationLaboratoriesLeadLuteinizing HormoneMacacaMacaca fascicularisMediatingMediator of activation proteinMessenger RNAMonkeysOocytesOvarianOvarian Hyperstimulation SyndromeOvarian StimulationsOvarian TissueOvaryOvulationPeptide HydrolasesPlayPrimatesProcessProductionProgesteroneProstaglandin ReceptorProstaglandinsProtein KinaseProteinsReproductionResearch PersonnelRiskRoleRole playing therapyRuptureSignal PathwaySignal TransductionSteroid biosynthesisTechniquesTestingTissuesgranulosa cellin vivolaser capture microdissectionnoveloocyte maturationpreventprogramsreceptorresearch studyresponsesteroid hormonesuccesstranscription factor
项目摘要
DESCRIPTION (provided by applicant): Ovulation is essential for successful reproduction. The ovulatory luteinizing hormone surge stimulates perieovulatory follicles to produce prostaglandin E2 (PGE2), which is required for expansion of the cumulus granulosa cells, follicle rupture, and oocyte release. Blockade of PGE2 production causes ovulation failure, supporting investigation of PGE2 as a treatment for infertility as well as inhibition of PGE2 synthesis/action as a potential contraceptive. To unravel the mechanism by which PGE2 stimulates perieovulatory events, this proposal puts forth the overall hypothesis that each of the four PGE2 (EP) receptors has a unique function in ovulation. First, we will determine which EP receptors are expressed by functionally-distinct subpopulations of granulosa cells within perieovulatory follicles. Using laser capture microdissection as well as immunofluorescent EP detection in monkey ovarian tissue sections, we will identify the EP receptor(s) present in cumulus, basal mural, and antral mural granulosa cells as well as granulosa cells located at the follicle apex. These subpopulations each play a unique role in ovulation, and we anticipate that each subpopulation expresses a unique subset of all EP receptors. Second, we will demonstrate that each EP receptor mediates a subset of all PGE2-stimulated preovulatory processes. PGE2 is known to stimulate granulosa cell progesterone production, cumulus expansion, and follicle rupture. Granulosa cell cultures as well as intrafollicular injection in macaques will be utilized to demonstrate that agonists specific for each EP receptor stimulate some, but not all, of these essential PGE2-mediated granulosa cell functions. Finally, we will determine which EP receptors can transduce the PGE2 signal in granulosa cells of primate preovulatory follicles. Granulosa cells will be treated with agonists specific for each of the four EP receptors, and intracellular signals generated via these G protein coupled receptors will be assessed. Each EP receptor will likely respond to agonist stimulation with a unique intracellular response. The proposed studies will likely demonstrate that each EP receptor mediates a specific subset of the total preovulatory response to PGE2 within the primate follicle. These data will facilitate a targeted pharmacological approach to selectively stimulate or inhibit essential features of the ovulatory process and may ultimately lead to the development of new treatments for infertility and novel contraceptive options.
描述(由申请人提供):排卵是成功繁殖的必要条件。促黄体生成素激增刺激排卵期卵泡产生前列腺素E2 (PGE2),这是卵泡颗粒细胞扩张、卵泡破裂和卵母细胞释放所必需的。阻断PGE2的产生导致排卵失败,支持PGE2作为治疗不孕症的研究,以及抑制PGE2的合成/作用作为一种潜在的避孕药。为了揭示PGE2刺激排卵期事件的机制,本研究提出了一个总体假设,即四种PGE2 (EP)受体中的每一种在排卵中都有独特的功能。首先,我们将确定哪些EP受体是由卵泡周围颗粒细胞的不同功能亚群表达的。利用激光捕获显微解剖和免疫荧光EP检测猴卵巢组织切片,我们将确定存在于积云、基底壁细胞和窦壁颗粒细胞以及位于卵泡顶端的颗粒细胞中的EP受体。这些亚群在排卵中发挥着独特的作用,我们预计每个亚群表达所有EP受体的独特亚群。其次,我们将证明每个EP受体介导所有pge2刺激的排卵前过程的一个子集。已知PGE2刺激颗粒细胞孕酮产生,积云扩张和卵泡破裂。颗粒细胞培养和猕猴的滤泡内注射将被用来证明每种EP受体特异性激动剂刺激一些,但不是全部,这些基本的pge2介导的颗粒细胞功能。最后,我们将确定哪些EP受体可以在灵长类动物排卵前卵泡颗粒细胞中转导PGE2信号。颗粒细胞将被四种EP受体的特异性激动剂处理,通过这些G蛋白偶联受体产生的细胞内信号将被评估。每个EP受体都可能对激动剂刺激产生独特的细胞内反应。拟议的研究可能会证明,每个EP受体介导灵长类动物卵泡内对PGE2的总排卵前反应的一个特定子集。这些数据将促进有针对性的药理学方法来选择性地刺激或抑制排卵过程的基本特征,并可能最终导致不孕不育的新治疗方法和新的避孕选择的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Diane M Duffy其他文献
Diane M Duffy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Diane M Duffy', 18)}}的其他基金
Prostaglandin Receptors in Primate Ovulatory Follicles
灵长类动物排卵卵泡中的前列腺素受体
- 批准号:
8072598 - 财政年份:2007
- 资助金额:
$ 34.24万 - 项目类别:
Prostaglandin Receptors in Primate Ovulatory Follicles
灵长类动物排卵卵泡中的前列腺素受体
- 批准号:
7842230 - 财政年份:2007
- 资助金额:
$ 34.24万 - 项目类别:
Prostaglandin Receptors in Primate Ovulatory Follicles
灵长类动物排卵卵泡中的前列腺素受体
- 批准号:
7624203 - 财政年份:2007
- 资助金额:
$ 34.24万 - 项目类别:
Prostaglandin Receptors in Primate Ovulatory Follicles
灵长类动物排卵卵泡中的前列腺素受体
- 批准号:
7842584 - 财政年份:2007
- 资助金额:
$ 34.24万 - 项目类别:
Prostaglandin Receptors in Primate Ovulatory Follicles
灵长类动物排卵卵泡中的前列腺素受体
- 批准号:
7313350 - 财政年份:2007
- 资助金额:
$ 34.24万 - 项目类别:
PROSTAGLANDIN ACTION IN THE PRIMATE PERIOVULATORY FOLLICLE
灵长类动物排卵期卵泡中前列腺素的作用
- 批准号:
6970603 - 财政年份:2004
- 资助金额:
$ 34.24万 - 项目类别:
CYCLOOXYGENASE EXPRESS & PROSTAGLANDIN PRODUCT BY PRIMAT PERIOVULATORY FOLLICLES
环加氧酶快递
- 批准号:
6592318 - 财政年份:2002
- 资助金额:
$ 34.24万 - 项目类别:
PROSTAGLANDINS IN PRIMATE OVULATORY FOLLICLES
灵长类动物排卵卵泡中的前列腺素
- 批准号:
6499157 - 财政年份:2001
- 资助金额:
$ 34.24万 - 项目类别:
CYCLOOXYGENASE EXPRESS & PROSTAGLANDIN PRODUCT BY PRIMAT PERIOVULATORY FOLLICLES
环加氧酶快递
- 批准号:
6453694 - 财政年份:2001
- 资助金额:
$ 34.24万 - 项目类别:
PROSTAGLANDINS IN PRIMATE OVULATORY FOLLICLES
灵长类动物排卵卵泡中的前列腺素
- 批准号:
6501792 - 财政年份:2001
- 资助金额:
$ 34.24万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 34.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 34.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别: